Glucosa Viaflex Baxter

Glucosa Viaflex Baxter is an intravenous solution containing glucose monohydrate as the active ingredient. It is supplied in a sterile liquid form for parenteral administration, primarily used in the European market. The product provides a source of carbohydrate energy and contributes to fluid balance when administered under medical supervision. It is typically stored at controlled temperature and must be handled according to aseptic technique to maintain sterility.

Glucosa Viaflex Baxter is indicated for several clinical situations where rapid carbohydrate delivery or fluid replacement is required.

- Management of acute hypoglycemia when oral glucose is not feasible. - Supplementation of caloric intake in patients receiving total parenteral nutrition. - Maintenance of intravascular volume and electrolyte balance during surgery or critical illness. - Support for patients with prolonged fasting or inability to ingest nutrients orally. - Adjunctive therapy for dehydration combined with electrolyte disturbances.

The safety profile of Glucosa Viaflex Baxter reflects the expected physiological response to intravenous glucose administration.

Common: - Transient hyperglycemia - Mild nausea or vomiting - Local irritation at the infusion site - Temporary increase in serum osmolality - Mild electrolyte shifts (e.g., sodium, potassium)

Serious: - Severe hyperglycemia leading to osmotic diuresis - Hypotension from rapid infusion - Allergic or anaphylactic reaction to the solution - Hyperosmolar hyperglycemic state in susceptible patients - Metabolic acidosis secondary to over‑infusion

Clinicians should observe specific precautions when prescribing Glucosa Viaflex Baxter to ensure patient safety and therapeutic effectiveness.

- Verify blood glucose level before and after infusion to avoid extreme fluctuations. - Adjust infusion rate in patients with renal or cardiac impairment to prevent fluid overload. - Use caution in individuals with known hypersensitivity to glucose solutions or excipients. - Monitor electrolytes, especially sodium and potassium, during prolonged administration. - Avoid use in patients with uncontrolled diabetes mellitus without close glucose monitoring. - Ensure proper aseptic technique to prevent catheter‑related infections.

Glucosa Viaflex Baxter may interact with other medications or clinical conditions; awareness of these interactions helps guide safe use.

Avoid: - Concurrent administration of high‑dose insulin without glucose monitoring. - Co‑infusion with hypertonic saline solutions that may exacerbate hyperosmolar states. - Use with drugs that significantly lower blood glucose (e.g., sulfonylureas) without adjusting doses.

Use with caution: - Combination with diuretics that affect fluid balance; monitor volume status. - Concurrent use of potassium‑sparing agents; watch for hyperkalemia. - Administration alongside catecholamines that can alter glucose metabolism; observe glucose trends.